Aprea Therapeutics (APRE) Misses Q1 EPS by 22c

Aprea Therapeutics (NASDAQ: APRE) reported Q1 EPS of ($0.22).

For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• QSE closes $6M private placement with final tranche of $674K
• Cytek faces $56M damages award in Beckman Coulter patent case